Table 1.
Phenotype | Cancer types | Role of Sirt4 | References |
---|---|---|---|
Sirt4 downregulation | Acute myeloid leukemia, Burkitt lymphoma, and lung, colorectal, gastric, liver, lung, endometrial, pancreatic, ovarian, prostate, and renal cancers | Cancer suppression: inhibition of tumor proliferation, invasion, and migration | (4, 33–35, 37–46) |
Sirt4 over-expression | Esophageal cancer, hepatocarcinoma (HepG2 cells) | Cancer promotion: enhanced cancer cell survival rate in “extreme” DNA-damaging conditios | (4, 47, 48) |